Company intelligence / Profile preview

Renovo Concepts

San Antonio, Texas, United Statesrenovoconcepts.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Renovo Concepts is developing a novel platform device—Mechanical Tissue Resuscitation™—to actively remove excess fluids from damaged tissues using controlled sub-atmospheric pressure. Preclinical studies have shown promising results in animal models for TBI and other organ injuries. The company received FDA Investigational Device Exemption and is enrolling patients in a Phase 1 safety study as of mid/late 2024

Therapeutic areas: CardiovascularNeurology
Modalities: DeviceNon-pharmacological therapy (Mechanical Tissue Resuscitation)
Industry: Therapeutic Medical Devices

Partnerships

Wake Forest University School of Medicine (technology origin/spinout)

Beyond the preview

Go deeper on Renovo Concepts.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renovo Concepts.

Explore the full profile